Clinical Trial Update: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma [Phase 1]

View source ↗

Summary

This clinical trial investigates pomalidomide in combination with liposomal doxorubicin for advanced or refractory Kaposi sarcoma. The Phase 1 study is active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kaposi Sarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING